Specific aspects of source medical documents in clinical studies on healthy volunteers

by S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev
Published 2018-05-01

Drug interchangeability: Clinical efficacy and safety

by S. K. Zyryanov, S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev
Published 2017-06-01

Multivariable Analysis of Primary Care Physician Adherence to Guideline-recommended Pharmacotherapy of Stable Coronary Artery Disease

by S. K. Zyryanov, S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebniova
Published 2021-03-01

The role of pharmacist in early phase clinical research

by A. V. Vozzhaev, S. B. Fitilev, V. A. Yakushev, I. I. Shkrebneva
Published 2018-05-01

The problem of over-volunteering in early phase clinical trials

by S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebniova, D. A. Kliuev
Published 2018-07-01

FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY)

by S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova
Published 2018-05-01

SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY)

by S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova
Published 2017-05-01

SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION

by S. B. Fitilev, D. A. Dimitrova, I. I. Shkrebneva, A. V. Vozzhaev
Published 2017-07-01

Clinical significance of TNF-a assessment as inflammation marker in paroxysmal atrial fibrillation

by E M Esedov, Z S Rustamova, S B Fitilev, I I Shkrebniova, A V Vozzhaev
Published 2014-12-01

Medication adherence in patients with cardiovascular disease: current view of the problem

by S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebniova, D. A. Kliuev, L. N. Stepanyan
Published 2020-04-01

Non-pharmacological secondary prevention of cardiovascular diseases in patients with stable angina at specialized ambulatory institution

by S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova, D. A. Dimitrova
Published 2018-05-01

The role of reference intervals of laboratory tests in early phase clinical research in healthy volunteers

by A. V. Vozzhaev, S. B. Fitilev, I. I. Shkrebniova, D. A. Kliuev, A. A. Vdovina, L. A. Miasnikova
Published 2018-07-01

Comparison of medicamental secondary prevention of cardiovascular disease in ambulatory patients with myocardial infarction over a period of 2001-2006 (pharmacoepidemiological stud...

by S B Fitilev, A V Vozzhaev, I I Shkrebneva, Y Y Titarova, E A Sicheva, R I Zhuravlev
Published 2009-03-01

Lipid-lowering therapy in outpatients of different ages with coronary artery disease

by S. K. Zyryanov, S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebniova, N. N. Landyshev, Ya. G. Voronko, A. M. Lutsenko
Published 2020-11-01

Assessing the implementation of the recommendations on secondary cardiovascular prevention in patients after myocardial infarction (a pharmaco-epidemiologic study)

by R. G. Oganov, V. K. Lepakhin, S. B. Fitilev, A. M. Levin, I. I. Shkrebneva, Yu. Yu. Titarova, A. V. Vozzhaev
Published 2009-08-01

Some safety aspects of a new russian pegylated interferon-A medication “ALGERON” (phase 1 clinical trial)

by A I Tukach, S B Fitilev, I I Shkrebniova, A V Vozzhaev, V A Yakushev, R A Ivanov, Yu N Lin’kova, T V Chernovskaya
Published 2014-12-01

Results of a phase I open randomized comparative crossover clinical trial to assess the safety and pharmacokinetics of Glurazyme® (imiglucerase) in comparison with the reference pr...

by S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebneva, D. A. Kudlay, E. V. Gapchenko, O. A. Markova, A. Yu. Borоzinets, A. A. Kazarov, М. S. Pantyushenko
Published 2019-12-01

Adherence to Medical Treatment in Elderly Patients with Coronary Artery Disease in the Settings of Primary Outpatient Care

by S. K. Zyryanov, S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebneva, N. N. Shindryaeva, D. A. Klyuev, L. N. Stepanyan, A. M. Lutsenko, A. T. Tsai, A. A. Danilova
Published 2021-05-01

Lipid-lowering therapy in patients with coronary artery disease in primary care practices: what has changed over 7 years?

by S. K. Zyryanov, S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebneva, D. A. Klyuev, L. N. Stepanyan, A. A. Danilova, A. T. Tsai, N. N. Landyshev, Ya. G. Voronko
Published 2020-09-01